DÍaz-Lobato S, Perales JMC, Iñigo JMA, Alises SM, Segovia B, et al. (2018) Things to Keep in Mind in High Flow Therapy: As Usual the Devil is in the Detail. Int J Crit Care Emerg Med 4:048.


© 2018 Díaz-Lobato S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ORIGINAL ARTICLE | OPEN ACCESSDOI: 10.23937/2474-3674/1510048

Things to Keep in Mind in High Flow Therapy: As Usual the Devil is in the Detail

Salvador Díaz-Lobato1*, José Manuel Carratalá Perales2, Jose miguel Alonso Iñigo3, Sagrario Mayoralas Alises4, Barbará Segovia5, Noelia Escalier6, Maria Inés Mattioli7, Ana Jaureguizar1 and Diurbis Velasco1

1Department of Pneumological, Ramón y Cajal Universitario Hospital, Spain

2Short-Stay Unit, Hospital General de Alicante, Spain

3Department of Anesthesiology, Critical Care and Pain Medicine, Hospital Universitario y Politécnico de La Fe, Spain

4Department of Pneumological, Clínica Moncloa, Spain

5Sanatorio Colegiales, Buenos Aires, Argentina

6Clínica Sagrada Familia, Buenos Aires, Argentina

7Sanatorio de la Trinidad-Mitre, Buenos Aires, Argentina


High-flow nasal cannula oxygen therapy (HFNC) has revolutionized the treatment of patients with respiratory failure in different settings. Several mechanisms of action explain us why HFNC has become a first line therapy for these patients. Some authors have referred to the adverse effects that can occur when we use HFNC and its limitations. However, there are numerous aspects that we should consider when prescribing this treatment and that are not documented in the literature to date. In a Task Force carried on by International High-Flow Network members in Madrid, the things that should be taken into account when put a patient on HFNC were addressed. We will discuss in this article aspects related to the device, oxygenation, humidification, tubing, nasal cannula, alarms and finally, those related to the patient who receive the treatment.